State Street Corporation 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 1:50 pm Sale | 2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 2,053,773 1.790% | -158,594 (-7.17%) | Filing |
| 2023-07-10 2:26 pm Sale | 2023-06-30 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 2,212,367 1.940% | -6,074,669 (-73.30%) | Filing |
| 2023-02-02 12:38 pm Purchase | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 8,287,036 7.320% | 2,773,356 (+50.30%) | Filing |
| 2022-02-11 08:38 am Sale | 2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 5,513,680 7.300% | -2,506,319 (-31.25%) | Filing |
| 2021-10-12 12:23 pm Purchase | 2021-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 8,019,999 10.620% | 2,680,140 (+50.19%) | Filing |
| 2021-02-11 3:09 pm Purchase | 2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 5,339,859 7.260% | 2,111,493 (+65.40%) | Filing |
| 2020-02-13 1:43 pm Purchase | 2019-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 3,228,366 5.140% | 3,228,366 (New Position) | Filing |